Details for Patent: 11,931,377
✉ Email this page to a colleague
Which drugs does patent 11,931,377 protect, and when does it expire?
Patent 11,931,377 protects INOMAX and is included in one NDA.
Protection for INOMAX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-five patent family members in six countries.
Summary for Patent: 11,931,377
| Title: | Methods of administering inhaled nitric oxide gas |
| Abstract: | The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide. |
| Inventor(s): | James S. Baldassarre |
| Assignee: | Mallinckrodt Hospital Products IP Unlimited Co , Mallinckrodt Pharma IP Trading DAC , Therakos Inc , Mallinckrodt Critical Care Finance Inc |
| Application Number: | US16/378,361 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,931,377
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Ireland | INOMAX | nitric oxide | GAS;INHALATION | 020845-004 | Jan 17, 2023 | RX | Yes | Yes | 11,931,377 | ⤷ Start Trial | Y | Y | A METHOD FOR TREATING A PEDIATRIC PATIENT WHO IS EXPERIENCING IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION RESULTING IN OXYGEN DESATURATION, WHEREIN THE PATIENT IS NOT DEPENDENT ON RIGHT-TO-LEFT SHUNTING OF BLOOD | ⤷ Start Trial | ||
| Mallinckrodt Ireland | INOMAX | nitric oxide | GAS;INHALATION | 020845-003 | Dec 23, 1999 | AA | RX | Yes | Yes | 11,931,377*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,931,377
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009202685 | ⤷ Start Trial | |||
| Australia | 2010202422 | ⤷ Start Trial | |||
| Australia | 2010206032 | ⤷ Start Trial | |||
| Australia | 2012201382 | ⤷ Start Trial | |||
| Australia | 2015100638 | ⤷ Start Trial | |||
| Australia | 2015100783 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
